17-alpha-hydroxypregnenolone has been researched along with nafarelin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, RB; Ehrmann, DA; Rosenfield, RL | 1 |
| Barnes, RB; Brigell, DF; Ehrmann, DA; Rosenfield, RL | 1 |
2 other study(ies) available for 17-alpha-hydroxypregnenolone and nafarelin
| Article | Year |
|---|---|
Studies of the nature of 17-hydroxyprogesterone hyperresonsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism.
Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androstenedione; Dexamethasone; Estradiol; Female; Follicle Stimulating Hormone; Humans; Hydroxyprogesterones; Hyperandrogenism; Luteinizing Hormone; Nafarelin; Ovarian Diseases; Testosterone | 1994 |
Ovarian steroidogenic responses to gonadotropin-releasing hormone agonist testing with nafarelin in hirsute women with adrenal responses to adrenocorticotropin suggestive of 3 beta-hydroxy-delta 5-steroid dehydrogenase deficiency.
Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; 3-Hydroxysteroid Dehydrogenases; Adolescent; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Dehydroepiandrosterone; Female; Hirsutism; Humans; Hydroxyprogesterones; Kinetics; Nafarelin; Ovary; Steroids; Testosterone | 1993 |